OTC vs Exchange: Regulatory Differences That Matter
The regulatory treatment of OTC crypto desks differs from spot exchanges in several important ways, even though both activities typically fall under the same VASP/CASP framework. Understanding these differences is essential for selecting the right licensing structure.
Order book vs. bilateral negotiation. Spot exchanges operate centralized or decentralized order books open to all users. OTC desks negotiate prices bilaterally with individual counterparties — typically for block trades above $50,000–$1,000,000. This bilateral nature means OTC desks serve a narrower client base (institutional, high-net-worth) but with higher transaction values and different risk profiles.
Client fund handling. Some OTC desks operate on a delivery-versus-payment (DvP) basis with no client funds held in custody — the desk simply connects buyers and sellers with simultaneous exchange of assets. Other OTC desks hold client funds temporarily during settlement, creating custody obligations. The former model (pure agency) carries lighter capital requirements in most jurisdictions; the latter (principal or custodial agency) triggers the same requirements as an exchange or custodian.
Counterparty due diligence. OTC desks typically serve institutional clients and high-net-worth individuals. KYB (Know Your Business) procedures are as important as KYC, and enhanced due diligence is expected for all counterparties regardless of transaction size. Source of funds verification for large block trades is a standard regulatory expectation in all jurisdictions where OTC licensing exists.
Travel Rule thresholds. OTC trades by their nature tend to exceed Travel Rule thresholds. OTC desks must implement Travel Rule compliance solutions for transfers above $1,000/$1,000 equivalent — in practice, this means Travel Rule applies to virtually every OTC transaction. Pre-trade counterparty verification (name, wallet address, and beneficial ownership) is standard practice for compliant OTC desks.
Principal vs Agency OTC Desk Models
The two dominant OTC business models have distinct regulatory implications. Before selecting a jurisdiction and license, determine which model your OTC desk will operate under.
AML and Travel Rule for OTC Desks
AML/CFT compliance for OTC desks has several features that distinguish it from retail exchange compliance. The higher transaction values and institutional counterparties create both greater risk and greater scrutiny from regulators.
Enhanced due diligence (EDD) thresholds. Most regulators require EDD for all transactions above a defined threshold — typically $15,000–$50,000 for OTC trades. EDD involves deeper investigation into the source of funds and wealth, beneficial ownership verification beyond standard KYB, and enhanced ongoing monitoring of the counterparty relationship. Given that most OTC trades exceed these thresholds, EDD is effectively the standard procedure for OTC operations rather than an exception.
Travel Rule implementation. FATF Recommendation 16 requires that originating VASPs transmit originator and beneficiary information to receiving VASPs for transfers above threshold. For OTC desks, this means verifying counterparty VASP identity (using tools like OpenVASP, Notabene, or TRM Labs), confirming wallet ownership, and maintaining records of all Travel Rule data exchanged. Many jurisdictions now require pre-trade Travel Rule checks before executing OTC transactions.
Institutional KYB. OTC clients are typically legal entities — funds, family offices, crypto companies, high-net-worth individuals via corporate structures. KYB procedures must verify the legal entity, its ultimate beneficial owners (UBOs, typically anyone with ≥25% ownership or control), source of business funds, and the commercial rationale for using OTC services. PEP and sanctions screening of all UBOs is mandatory.
- Full KYB/KYC on all OTC counterparties before first trade
- UBO verification with ≥25% ownership threshold
- Source of funds and wealth verification for trades above EDD threshold
- Travel Rule compliance for all transfers above $1,000 threshold
- PEP and sanctions screening (OFAC, EU, UN) on all parties
- Ongoing transaction monitoring with risk-based thresholds
- Suspicious activity reporting to national FIU as required
Best Jurisdictions for an OTC Crypto License
OTC desks serving institutional clients benefit from jurisdictions with strong regulatory credibility. The following jurisdictions offer the most practical licensing frameworks for OTC and broker operations in 2025.
| Jurisdiction | License Type | Timeline | Min Capital | Corp Tax |
|---|---|---|---|---|
| Estonia (FIU) | OTC VASP | 3–6 months | €100,000 | 20% |
| Lithuania (FCIS) | OTC VASP | 2–4 months | €125,000 | 15% |
| UAE VARA | OTC Broker License | 6–12 months | $400,000 | 0% |
| Switzerland (FINMA) | VASP + Broker | 6–12 months | CHF 300,000 | 8.5% |
| Seychelles (FSA) | OTC VASP | 2–4 months | $50,000 | 0% |
| Gibraltar (GFSC) | DLT Provider | 4–8 months | £100,000 | 10% |
How to Apply for an OTC Crypto License
The OTC crypto licensing process follows the same general structure as a VASP license application, but with additional emphasis on institutional client documentation, Travel Rule compliance infrastructure, and counterparty risk management. Allow 6–10 weeks for preparation.
OTC Crypto License Cost Comparison
OTC licensing costs are broadly similar to standard VASP licensing but with additional spend on Travel Rule compliance infrastructure and institutional KYB tooling. The ranges below cover the most popular OTC jurisdictions.
| Cost Component | Seychelles | Lithuania | UAE VARA |
|---|---|---|---|
| State / Regulatory Fees | $5,000–$10,000 | €1,500–€3,000 | $20,000–$40,000 |
| Legal & Advisory Fees | $10,000–$20,000 | €15,000–€30,000 | $40,000–$80,000 |
| AML & Travel Rule Setup | $5,000–$15,000 | €8,000–€20,000 | $15,000–$30,000 |
| Minimum Capital (locked) | $50,000 | €125,000 | $400,000 |
| Total Estimated Range | $70K–$95K | €149K–€178K | $475K–$550K |